Back to Agenda
Session 5 Track A: Transparency and Openness
Session Chair(s)
Vratislav Hadrava, MD, PHD
Vice President and Medical Director, Global Innovative Products, Pfizer Canada, Inc., Canada
The session will review the pre-market transparency initiatives underway within the Health Products and Food Branch, provide update and next steps as well as the evolution of the post-market clinical data transparency within industry, the different models of data sharing initiatives and industry endorsement of data sharing principles.
Learning Objective : At the conclusion of the session, participants should be able to: • Define the pre-market transparency initiatives underway within the Health Products and Food Branch • Understand the progression of the initiatives since their inception • Identify possibilities for future expansion of the transparency initiatives
Speaker(s)
Jessica S. Scott, JD, MD
President, Legacy Health Strategies , United States
Speaker
Laura Johnson
Project Manager, Health Canada, Canada
Update on Premarket Transparency in the Health Products and Food Branch, Health Canada
Rebecca Bose
Policy Division-Policy Science Int'l Programs, Therapeutic Products Directorate , Health Canada, Canada
Speaker
Sandra A. Morris, PHD, PMP
Vice President, Strategy Realization, Johnson & Johnson, United States
Speaker
Marla Jo Brickman, PHD
Senior Director - Clinical Data Transparency/Compassionate Access Lead, Pfizer Inc, United States
Speaker
Have an account?